Varian inks software development deal with MD Anderson October 18, 2019 -- Radiation therapy firm Varian Medical Systems has signed an agreement with University of Texas MD Anderson Cancer Center to develop software designed to streamline the review of radiation oncology treatment plans.
RT improves elderly brain cancer patient survival October 18, 2019 -- A radiation therapy (RT) treatment that combines radiation with chemotherapy can improve survival rates in elderly brain cancer patients, according to research presented on October 17 at the annual meeting of the Royal Australian and New Zealand College of Radiologists (RANZCR) in Auckland.
IMV: Imaging boosts precision in radiation therapy October 17, 2019 -- Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, such as the growing use of imaging, according to a new report by IMV Medical Information Division. Discuss
ImaginAB signs collaboration deal with 3 firms October 15, 2019 -- Imaging agent developer ImaginAb has signed a collaboration agreement with pharmaceutical companies AstraZeneca, Pfizer, and Takeda Pharmaceutical to further the clinical development of its CD8 PET technology.
Varian reports Flash therapy milestone October 14, 2019 -- Radiation therapy firm Varian Medical Systems announced that it has achieved an important milestone in the research of Flash therapy technology in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center.
Shine forms therapeutics division October 14, 2019 -- Medical isotope firm Shine Medical Technologies has launched Shine Therapeutics, a new division that will target the market for therapeutic isotopes.
Q BioMed, Jubilant Radiopharma to partner October 3, 2019 -- Biotech company Q BioMed and Jubilant Radiopharma have announced an agreement regarding the distribution of a cancer palliation radiopharmaceutical in the U.S.
Xstrahl inks supplier deal October 3, 2019 -- X-ray and radiation therapy technology developer Xstrahl has signed a deal with C&C Irradiator Service of Washington, DC, to supply x-ray irradiator systems that will replace cesium sources across the U.S.
Radiation therapy (RT) could be more effective in African-American men with prostate cancer than previously realized, according to data presented at the American Society for Radiation Oncology (ASTRO) annual meeting. Read more